MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells
Jian Wu(Sun Yat-sen University), Liping Xie(First Affiliated Hospital Zhejiang University), Yunfu Liu(First Affiliated Hospital Zhejiang University), Yi Zhu(Xuzhou Medical College), Alin Ji(Zhejiang Provincial People's Hospital), Yasai Yu(First Affiliated Hospital Zhejiang University), Xiao Wang(Qingdao University), Shiqi Li(Zhejiang University), Zhen Liang(Capital Medical University), Xiangyi Zheng(Tianjin University), Xin Xu(Dalian Medical University), Yiwei Lin(First Affiliated Hospital Zhejiang University)
Cited by 89
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276